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Immobilization of an artificial imine reductase
within silica nanoparticles improves its
performance†
Martina Hestericova´,a M. Rita Correro,b Markus Lenz,c Philippe F.-X. Corvini,c
Patrick Shahgaldian*b and Thomas R. Ward*a
Silica nanoparticles equippedwith an artificial imine reductase display
remarkable activity towards cyclic imine- and NAD+ reduction. The
method, based on immobilization and protection of streptavidin on
silica nanoparticles, shields the biotinylated metal cofactor against
deactivation yielding over 46000 turnovers in pure samples and
4000 turnovers in crude cellular extracts.
Catalysis plays a crucial role in a variety of scientific fields
including synthetic organic chemistry. Given this importance, a
wide range of synthetic systems, including heterogeneous
solids, organocatalysts, metal complexes and enzymes, have
been developed in the past century.1 Transition metal catalysts
and enzymes possess complementary properties, which can be
exploited in the synthesis of various enantiopure compounds.2
The industrial use of enzymes is partially limited by their
operational instability and, in some cases, high price.3 Therefore,
significant eﬀorts have been invested in developing immobilization
strategies that may contribute to stabilize enzymes, while allowing
their recycling.4
An artificial metalloenzyme (ArM) results from the incorporation
of a synthetic metal complex cofactor within a host protein.5 The
biotin–streptavidin technology has been widely exploited to ensure
the localization of a biotinylated cofactor within the host protein.6
As ArMs often bear a soft metal, cellular metabolites, including
organosulfur compounds present in the E. coli cellular debris, fre-
quently deactivate the metal.7 Such hybrid catalysts can be viewed as
complementary to both homogeneous catalysts and enzymes.2,8–14
d6-piano stool complexes have shown great potential for
in vivo catalysis as they display promising stability in biological
environments.15 With the aim of improving its catalytic perfor-
mance, we set out to shield an artificial transfer hydrogenase
(ATHase) in a protective organosilica layer on silica nano-
particles (SNPs) and evaluate its catalytic performance towards
the reduction of imines and the regeneration of NAD+.16
Working on the development of nanomaterials endowed with
virus recognition properties,17,18 we have designed a chemical
strategy that allows embedding enzymes in a biomimetic and
soft organosilica layer.19,20
In the present work, we have expanded this shielding strategy to
artificial metalloenzymes and tested the resulting nanocatalysts for
the reduction of cyclic imine 1 in the presence of various cellular
extracts. As shown previously with soluble ArMs, embedding the
biotinylated pianostool iridium complex [Cp*Ir(biot-p-L)Cl] within
various streptavidinmutants (Sav hereafter) allows to access either
(R)- and (S)-salsolidine 2 (Fig. 1), depending on the Sav mutant
(Table 1). This observation ensures that the biotinylated cofactor
[Cp*Ir(biot-p-L)Cl] is indeed incorporated within Sav, as the bare
cofactor yields (rac)-salsolidine 2.
Fig. 1 (a) Immobilization and protection of ATHase in a protective organosilica
layer yielding active and protected nanoparticles. The ATHase is covalently
anchored (1) on the surface of SNPs (dark grey), followed by self-assembly and
polycondensation of silanes (2), which eventually build a protective layer (3).
(b) ATHase of cyclic imine and structure of the iridium cofactors.
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Single mutants [Cp*Ir(biot-p-L)Cl]S112A Sav and [Cp*Ir(biot-
p-L)Cl]S112K Sav were selected for immobilization and protection.
These ArMs aﬀord opposite enantiomers of amine 2. Additionally,
the double mutant [Cp*Ir(biot-p-L)Cl]S112A-K121A Sav was
selected for immobilization in view of its remarkable activity
as purified ArM.21
Native SNPs (240 nm in diameter) were prepared by the Sto¨ber
method.22 Next, in order to covalently anchor Sav on the surface of
the nanoparticles, the SNPs were amino-modified by incubation
with (3-aminopropyl)-triethoxysilane (APTES) and further reacted
with glutaraldehyde. Sav isoforms preincubated with the iridium
cofactor, [Cp*Ir(biot-p-L)Cl]S112A Sav, [Cp*Ir(biot-p-L)Cl]S112K
Sav and [Cp*Ir(biot-p-L)Cl]S112A-K121A Sav, were immobilized
at the surface of SNPs by reacting with the free aldehyde
functions present at the surface of the SNPs. The synthesis of
a protective organosilica layer was achieved by incubating the
SNPs with tetraethyl orthosilicate and APTES for one- and four
hours respectively, yielding protected SNPs (prot-SNPs, Fig. 2).
SNPs were imaged using a field emission scanning electron
microscope (FESEM). The micrographs revealed monodisperse and
well-defined nanoparticles with an average diameter of 260 nm. As
illustrated in Fig. 2, the SNPs equipped with the additional protec-
tive silica layer (prot-SNPs) display a homogeneous size distribution
with a diameter increase of approx. 10 nm upon protection.
Gratifyingly, immobilization and additional protection of
the ATHase on the SNPs to yield [Cp*Ir(biot-p-L)Cl]Sav@SNP
and [Cp*Ir(biot-p-L)Cl]Sav@prot-SNP respectively only led to a
modest variation of the enantioselectivity of the hybrid catalyst
towards the reduction of imine 1 (Table 1, entries 6 and 10).
The activity (i.e. total turnover number, TON) of the SNPs was
established based on the iridium concentration. This latter was
determined by inductively coupled plasma mass spectrometry
(ICP-MS) for each SNP batch. Dried SNPs contain approximately
0.04 ng Ir per mg SNPs. Salsolidine reduction using [Cp*Ir(biot-
p-L)Cl]S112A Sav SNPs yielded total TON of 4294 after 2 days
(Table 2, entry 1).
In line with the performance of the soluble ArM, the
immobilized [Cp*Ir(biot-p-L)Cl]S112A-K121A Sav@prot-SNP
yielded the best results, with TON of 12885 and almost full
conversion (entry 11). Upon increasing the substrate concen-
tration (200 mM), a TON of 46 747 was obtained using SNPs
with [Cp*Ir(biot-p-L)Cl]S112A-K121A Sav@prot-SNP (entry 14).
Compared to the homogeneous ArMs (entries 5, 10 and 15
respectively), the TONs are significantly increased, at the cost
of slight erosion in selectivity. We hypothesize that the increased
rate results from the protective eﬀect of the organosilane layer
combined with the increased hydrophobicity around the active
site. The preferential formation of enantioenriched salsolidine 1,
depending on the Sav mutant, unambiguously demonstrates
that the SNPs indeed contain the intact ArMs with preserved
quaternary structure. Importantly, the SNPs can be recycled at
least twice, at the cost of an erosion in conversion (entries 2, 3, 7,
8, 12 and 13), yet with virtually the same enantiomeric excess.
Control experiments with native SNPs or SNPs without the
presence of Sav (e.g. empty SNPs) did not show any activity
towards NAD+ or imine reduction (entries 16 and 17). To address
the synergistic eﬀect of the silica layer and the streptavidin
host on the catalytic performance of the iridium cofactor,
a non-biotinylated [Cp*Ir(4C-L)Cl] analog was synthesized,
immobilized and protected within SNPs ([Cp*Ir(4C-L)Cl]@prot-
SNP). In contrast to the ArM, upon immobilization, the activity of
[Cp*Ir(4C-L)Cl]@prot-SNP decreases upon mineralization within
SNPs, (Table 2, entries 19 and 20).
We have also demonstrated the stability of enantioselectivity
over time (see ESI†). The time-point assay showed only a slight
erosion of enantioselectivity over the course of 7 days (decrease
of 11%), which could be explained by disruption of the protective
layer and leakage of the catalyst caused by friction in solution.20
However, the ICP-MS measurements of the reaction medium
after the reaction revealed only traces of iridium. We thus argue
that the decrease in activity is predominantly caused by loss of
nanoparticles during centrifugation and washing cycles.
With biomedical applications23 in mind, we evaluated the
regeneration of NAD+ by [Cp*Ir(biot-p-L)Cl]S112A Sav@prot-
SNP. For this purpose, the formation of NADH was monitored
by absorbance spectroscopy at 340 nm (for detailed data
see ESI†). The results confirm that the immobilization does
not significantly aﬀect the catalytic properties of the hybrid
catalysts towards the NAD+ reduction. The protected catalyst
[Cp*Ir(biot-p-L)Cl]Sav@prot-SNP has a initial lower reaction rate,
but overall slightly improved TONs compared to [Cp*Ir(biot-p-
L)Cl]Sav.
Table 1 Reactions performed using purified proteins
Entry Sav mutant eea,b (%) Conv.a (%) TON
1 [Cp*Ir(biot-p-L)Cl]Sav WT 38 70 140
2 [Cp*Ir(biot-p-L)Cl]S112A 87 89 178
3 [Cp*Ir(biot-p-L)Cl]S112K 70 86 173
4 [Cp*Ir(biot-p-L)Cl]K121A 35 99 198
5 [Cp*Ir(biot-p-L)Cl]S112A-K121A 79 98 196
6 [Cp*Ir(biot-p-L)Cl]R84A-S112A-K121A 68 99 198
Reactions were performed in 200 ml of reaction mixture. a Enantiomeric
excess and conversion were determined by HPLC analysis on a
Chiralpak-IC column. b Positive ee values correspond to (R)-salsolidine
and negative ee values correspond to (S)-salsolidine.
Fig. 2 Scanning electron micrographs of the SNPs; (A) native amino-
modified SNPs, (B) [Cp*Ir(biot-p-L)Cl]S112A@prot-SNP, (C) [Cp*Ir(biot-p-
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In order to test the compatibility of SNPs with complex
cellular media, we performed experiments in the presence of
E. coli cell lysates.
In stark contrast to the homogenous ArMs, which lose most of
their activity in the presence of cellular debris solution, the SNPs
partially maintained their catalytic activity. Up to 80 TONs were
achieved with [Cp*Ir(biot-p-L)Cl]S112A Sav@prot-SNPs and 171
TONs with [Cp*Ir(biot-p-L)Cl]S112K Sav@prot-SNPs (for detailed
data see ESI†). Other complex media were evaluated with
[Cp*Ir(biot-p-L)Cl]S112A-K121A Sav@prot-SNPs (Table 3).
Up to 4500 TONs were obtained upon performing the imine
reduction in urine. SNPs maintain their catalytic activity also
in the presence of methanol (4000 TONs, accompanied by an
erosion in ee), which results in protein denaturation without
the presence of protective organosilane layer and a complete
loss of activity (Table 3, entries 9 and 10).
The catalytic experiments reported herein reveal several
noteworthy features:
(i) Immobilization of Sav isoforms on silica nanoparticles
and their protection with organosilane layer yields catalysts
with higher turnover number rates compared to the use of
purified proteins.
(ii) Such nanoparticles can be recycled up to three times with
only a slight erosion in selectivity.
(iii) Protected catalysts can withstand the presence of cellular
debris without the need of diamide pretreatment.7
Table 2 Asymmetric imine reduction yielding salsolidine 2 using silica nanoparticles equipped with an artificial transfer hydrogenase
Entry Sav sourcea Ir concentrationb (mM) eec,d (%) Conv.c (%) TON
1 [Cp*Ir(biot-p-L)Cl]S112A@prot-SNP 2.6 90 56 4294
2 [Cp*Ir(biot-p-L)Cl]S112A@prot-SNP 1st recycling 2.6 83 28 2172
3 [Cp*Ir(biot-p-L)Cl]S112A@prot-SNP 2nd recycling 2.6 80 24 1863
4 [Cp*Ir(biot-p-L)Cl]S112A@prot-SNP 200 mM substratee 2.6 88 22 16 990
5 [Cp*Ir(biot-p-L)Cl]S112A Sav purified protein f 2.6 79 15 1154
6 [Cp*Ir(biot-p-L)Cl]S112K@prot-SNP 1.2 56 22 3775
7 [Cp*Ir(biot-p-L)Cl]S112K@prot-SNP 1st recycling 1.2 53 12 2000
8 [Cp*Ir(biot-p-L)Cl]S112K@prot-SNP 2nd recycling 1.2 58 9 1580
9 [Cp*Ir(biot-p-L)Cl]S112K@prot-SNP 200 mM substratee 1.2 48 10 16 667
10 [Cp*Ir(biot-p-L)Cl]S112K Sav purified protein f 1.2 66 5 833
11 [Cp*Ir(biot-p-L)Cl]S112A-K121A@prot-SNP 1.5 70 97 12 885
12 [Cp*Ir(biot-p-L)Cl]S112A-K121A@prot-SNP 1st recycling 1.5 68 56 7294
13 [Cp*Ir(biot-p-L)Cl]S112A-K121A@prot-SNP 2nd recycling 1.5 67 50 6570
14 [Cp*Ir(biot-p-L)Cl]S112A-K121A@prot-SNP 200 mM substratee 1.5 76 36 46 747
15 [Cp*Ir(biot-p-L)Cl]S112A-K121A Sav purified protein f 1.5 89 19 2513
16 Native SNPs 0 0 0 0
17 Empty prot-SNPs 0 0 0 0
18 [Cp*Ir(biot-p-L)Cl] freeg 2.6 0 8 444
19 [Cp*Ir(4C-L)Cl] free g 80 0 42 104
20 [Cp*Ir(4C-L)Cl]@prot-SNPs 80 0 26 66
a Reactions performed in a reaction buﬀer using 1 mg of SNPs in 100 ml reaction mixture with 20 mM substrate concentration at RT for 48 hours.
b Determined by means of ICP-MS. c The enantiomeric excess and conversion were determined by HPLC analysis on a Chiralpak-IC column (see
ESI for details). d Positive ee values correspond to (R)-salsolidine 2 and negative ee values correspond to (S)-salsolidine 2. e Reactions performed in
a reaction buﬀer using 1 mg of SNPs in 100 ml reaction mixture with 200 mM substrate concentration for 48 hours. f Reactions were performed with
free purified enzymes with the same iridium concentration as used with SNPs. g Reactions performed without the presence of Sav using the
iridium ligand 10 [Cp*Ir(4C-L)Cl] in reaction buﬀer.
Table 3 Asymmetric imine reduction yielding salsolidine 2 using [Cp*Ir(biot-p-L)Cl]S112A-K121A Sav@prot-SNP
Entry SNP Cellular debrisa eeb,c (%) Conv.b (%) TON
1 [Cp*Ir(biot-p-L)Cl]S112A-K121A Sav@prot-SNP Milk 41 24 2569
2 Yeast extract 37 1 158
3 Urine pH 6 25 11 4554
4 Blood pH 7 35 1 392
5 Blood serum 27 6 862
6 Empty vector CFE 89 3 1873
7 Empty vector CL 33 1 132
8 GSH 5 mM 30 0.15 20
9 MeOH 50% 14 30 4024
10 [Cp*Ir(biot-p-L)Cl]S112A-K121A Sav purified proteind MeOH 50% 0 0 0
Reactions were performed in a reaction buﬀer using 1 mg of SNPs in 100 ml reaction mixture with 20 mM substrate concentration at RT for
48 h. a Reaction mixture contained 48 ml of crude cellular extract, organic solvent or stock solution of glutathione. b Enantiomeric excess and
conversion were determined by HPLC analysis on a Chiralpak-IC column. c Positive ee values correspond to (R)-salsolidine 2 and negative ee values





















































































This journal is©The Royal Society of Chemistry 2016 Chem. Commun., 2016, 52, 9462--9465 | 9465
(iv) The protective layer also prevents the protein denatura-
tion in the presence of chaotropic agents.
In summary, we have successfully developed an artificial
biocatalyst consisting of a pianostool iridium cofactor within
Sav immobilized in SNPs. These nanoparticles display remark-
able catalytic activity with TON4 46 000 using aqueous solutions
and TON 4 4000 in the presence of cellular debris. Presented
SNPs oﬀer interesting perspectives towards green chemistry as
they operate under nearly physiological conditions and can be
recycled with only a slight erosion of reactivity. Immobilization
and protection of artificial metalloenzymes on silica nano-
particles represents a promising technique for activity enhance-
ment of such hybrid catalysts. The next steps will include
cellular uptake and engineering enzyme cascades incorporating
natural and artificial metalloenzymes within SNPs.
This research was supported by the Swiss Nanoscience
Institute (Project NanoZyme, DPA2238) and the NCCR Molecu-
lar Systems Engineering.
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